Proteomic Analysis of Bone Marrow CD138+ Cells to Identify Proteins Associated With the Response of Multiple Myeloma Patients to Commonly Used Therapeutic Regimens

Ähnliche Einträge

• Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple Myeloma
  von: Maria Frantzi, et al.
  Veröffentlicht: (2026)
• A Proteomics Resource Investigating Fibrosis: Proof‐of‐Concept for Identifying Novel Drug Candidates
  von: Hanne Devos, et al.
  Veröffentlicht: (2025)
• Response to “Determinants of Ultra‐Long‐Term Survival in Multiple Myeloma: A Critical Appraisal of Foundational Assumptions and a Call for Biologically Driven Inquiry”
  von: Meletios A. Dimopoulos, et al.
  Veröffentlicht: (2026)
• Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials
  von: Ioannis Ntanasis‐Stathopoulos, et al.
  Veröffentlicht: (2025)
• Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First‐Line Treatment
  von: Polyxeni Spiliopoulou, et al.
  Veröffentlicht: (2025)